galantamine has been researched along with 3-nitropropionic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, K; Im, WS; Kim, M; Lee, ST; Park, JE | 1 |
| Aw, CC; Browne, ER; Chan, EC; Chang, KL; Goh, CW; Mal, M; New, LS | 1 |
2 other study(ies) available for galantamine and 3-nitropropionic acid
| Article | Year |
|---|---|
Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Galantamine; Huntington Disease; In Situ Nick-End Labeling; Male; Nerve Degeneration; Neurologic Examination; Nitro Compounds; Nootropic Agents; Propionates; Rats; Rats, Inbred Lew; Statistics, Nonparametric | 2008 |
Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry.
Topics: Animals; Brain; Disease Models, Animal; Electron Transport Complex II; Galantamine; Gas Chromatography-Mass Spectrometry; Huntington Disease; Metabolome; Metabolomics; Mitochondria; Nitro Compounds; Nootropic Agents; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley | 2011 |